Norris Medicines Limited (NORRIS.BO)
INR 19.21
(-1.99%)
INR 19.21
(-1.99%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 56.35 Million | 83.58 Million | 94.38 Million | 122.51 Million | 78.43 Million | 162.66 Million |
| Cost of Revenue | 26.99 Million | 35.22 Million | 57.25 Million | 89.07 Million | 47.54 Million | 104.24 Million |
| Gross Profit | 29.36 Million | 48.35 Million | 37.13 Million | 33.43 Million | 30.88 Million | 58.41 Million |
| Operating Expenses | 18.2 Million | 45.51 Million | 44.36 Million | 57.3 Million | 59.25 Million | 71.54 Million |
| Selling, General and Administrative Expenses | 18.2 Million | 23 Million | 23.37 Million | 31 Million | 32.35 Million | 38.22 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 45.19 Million | 80.74 Million | 101.61 Million | 146.37 Million | 106.8 Million | 175.79 Million |
| Operating Income | 11.15 Million | 2.97 Million | -7.19 Million | -24.08 Million | -28.45 Million | -13.1 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 888.71 Thousand | 5.56 Million | 10.78 Million | 9.68 Million | 8.39 Million | 3.34 Million |
| Earnings before Tax | -10.97 Million | -11.93 Million | -21.84 Million | -39.93 Million | -36.81 Million | -20.1 Million |
| Net Income | -11.86 Million | -17.49 Million | -32.63 Million | -49.61 Million | -28.41 Million | -16.76 Million |
| Earnings Per Share Basic | -1.19 | -1.75 | -3.26 | -4.96 | -2.84 | -1.68 |
| Earnings Per Share Diluted | -1.19 | -1.75 | -3.26 | -4.96 | -2.84 | -1.68 |
| Weighted Average Shares Outstanding | 9.97 Million | 9.99 Million | 10 Million | 10 Million | 10 Million | 9.97 Million |
| Weighted Average Shares Outstanding (Diluted) | 10 Million | 10 Million | 10 Million | 10 Million | 10 Million | 10 Million |
| Gross Margin | 0.52 | 0.58 | 0.39 | 0.27 | 0.39 | 0.36 |
| EBIT Margin | -0.03 | 0.11 | -0.01 | -0.14 | -0.27 | -0.04 |
| Profit Margin | -0.21 | -0.21 | -0.35 | -0.41 | -0.36 | -0.10 |
| EBITDA | -1.78 Million | 9.27 Million | -630.44 Thousand | -17.42 Million | -21.16 Million | -5.97 Million |
| Earnings Before Tax Margin | 0.20 | 0.04 | -0.08 | -0.20 | -0.36 | -0.08 |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 7.24 Million | 14.87 Million | 56.35 Million | 6.46 Million | 25.55 Million | 9.46 Million |
| Cost of Revenue | 1.72 Million | 2.2 Million | 26.58 Million | 542 Thousand | 20.21 Million | 3.62 Million |
| Gross Profit | 5.52 Million | 12.66 Million | 29.76 Million | 5.92 Million | 5.33 Million | 5.84 Million |
| Operating Expenses | 8.34 Million | 8.91 Million | 37.04 Million | 7.76 Million | 9.23 Million | 11.12 Million |
| Selling, General and Administrative Expenses | 3.43 Million | 4.09 Million | - | 3.37 Million | 4.76 Million | 5.97 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 10.06 Million | 11.12 Million | 63.63 Million | 8.3 Million | 29.45 Million | 14.75 Million |
| Operating Income | -2.93 Million | 3.46 Million | -7.56 Million | -1.84 Million | -3.9 Million | -5.28 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | - | 889 Thousand | 889 Thousand | - | - | - |
| Earnings before Tax | -3.66 Million | 2.63 Million | -10.97 Million | -2.7 Million | -4.76 Million | -6.14 Million |
| Net Income | -3.66 Million | 1.74 Million | -11.86 Million | -2.7 Million | -4.76 Million | -6.14 Million |
| Earnings Per Share Basic | -0.37 | 0.17 | - | -0.27 | -0.48 | -0.61 |
| Earnings Per Share Diluted | -0.37 | 0.17 | - | -0.27 | -0.48 | -0.61 |
| Weighted Average Shares Outstanding | 9.89 Million | 10.27 Million | 9.97 Million | 10.01 Million | 9.92 Million | 10.08 Million |
| Weighted Average Shares Outstanding (Diluted) | 9.89 Million | 10.27 Million | 9.97 Million | 10.01 Million | 9.92 Million | 10.08 Million |
| Gross Margin | 0.76 | 0.85 | 0.53 | 0.92 | 0.21 | 0.62 |
| EBIT Margin | -0.21 | 0.33 | - | -0.04 | -0.10 | -0.39 |
| Profit Margin | -0.51 | 0.12 | -0.21 | -0.42 | -0.19 | -0.65 |
| EBITDA | -1.5 Million | 4.89 Million | - | -269.44 Thousand | -2.46 Million | -3.71 Million |
| Earnings Before Tax Margin | -0.40 | 0.23 | -0.13 | -0.29 | -0.15 | -0.56 |
APOORVA
2237
000060
POEL
EPACK
EALT3